Bernadette C. Fendrock (Bonnie), President and CEO
John K. McGeehan (Jack), Vice President, Operations
Mann Shoffner, Director, Marketing and Sales
Bernadette C. Fendrock (Bonnie) President and CEO
Ms. Fendrock is co-founder, president and CEO of Hepregen. Ms. Fendrock comes to Hepregen with more than twenty years of commercial experience in the life sciences industry. As vice president at Genzyme Corporation, Ms. Fendrock was responsible for the commercial planning and market launch of biosurgical products to treat post operative adhesions. Prior to Genzyme, Ms. Fendrock held positions as director of business development, Somatix, Inc., a start-up gene therapy company, and project manager, Genetics Institute (now Wyeth). Ms. Fendrock also has been a business consultant for the Harvard-MIT Division of Health Sciences and Technology and the Biomedical Enterprise Program (a collaboration with The Sloan School at MIT) and Acusphere, Inc. Ms. Fendrock holds a B.A. degree with a major in molecular biology from Wellesley College, a S.M. degree from MIT in interdisciplinary science and an M.B.A. from The Wharton School of the University of Pennsylvania.
John K. McGeehan (Jack) Vice President, Operations
Mr. McGeehan joined Hepregen in March, 2009 with over 25 years of technical and management experience in the biotechnology industry. Mr. McGeehan was a co-founder of ActiMed Laboratories, Inc., a medical device company. While at ActiMed, he invented a novel, patented, non-instrumented clinical chemistry test platform and advanced manufacturing technologies. He was responsible for managing the budget, design, and construction of a $15M computerized, state-of the-art GMP fully automated manufacturing facility. As vice president of operations, Mr. McGeehan guided the development, scale-up, manufacture, and clinical trials, of the ENA•C•T® Total Cholesterol test. Prior to ActiMed, Mr. McGeehan was employed in positions of increasing responsibility at a division of E. Merck. Mr. McGeehan managed the construction and start-up of a $1M dry powder manufacturing facility. He leveraged the fluid bed granulation technology into five distinct diagnostic reagent product lines, taking over 100 products to successful market introductions. Most recently, as a founder of Innova Medical Technologies, Inc., Mr. McGeehan provided general consulting and product development services to medical product companies. Mr. McGeehan holds a B.A. in biology from Millersville University and a M.S. in biomedical engineering from Drexel University. He is named as an inventor on seven US patents.
Mann Shoffner Director, Marketing and Sales
Mr. Shoffner is an experienced sales manager with a 15 year track record in sales, marketing and business development of life sciences companies. He most recently led the commercialization efforts at SRU Biosystems, Inc. For the seven years prior, he established and ran the international sales department for Agencourt Bioscience, Corp., now Beckman Coulter Genomics. Mr. Shoffner holds a M.S. in management of technology from Sloan School at MIT and a B.S. in bioengineering from the University of Pennsylvania.